TGF-β1 inhibits surfactant component expression and epithelial cell maturation in cultured human fetal lung
- 1 November 1998
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 275 (5) , L950-L960
- https://doi.org/10.1152/ajplung.1998.275.5.l950
Abstract
Transforming growth factor-β1 (TGF-β1) is a multifunctional cytokine shown to play a critical role in organ morphogenesis, development, growth regulation, cellular differentiation, gene expression, and tissue remodeling after injury. We examined the effect of exogenously administered TGF-β1 on the expression of surfactant proteins (SPs) and lipids, fatty acid synthetase, and ultrastructural morphology in human fetal lung cultured for 5 days with and without dexamethasone (10 nM). Expression of the type II cell-specific marker surfactant proprotein C (proSP-C), studied by [35S]Met incorporation and immunoprecipitation, increased sevenfold with dexamethasone treatment. TGF-β1 (0.1–100 ng/ml) in the presence of dexamethasone inhibited 21-kDa proSP-C expression in a dose-dependent manner (maximal inhibition 31% of control level at 100 ng/ml). There was no change in [35S]Met incorporation into total protein in any of the treatment groups vs. the control group. In immunoblotting experiments, TGF-β1 blocked culture-induced accumulation of SP-A and SP-B. Under the same conditions, TGF-β1 reduced mRNA content for SP-A, SP-B, and SP-C to 20, 38, and 41%, respectively, of matched control groups but did not affect levels of β-actin mRNA. SP transcription rates after 24 h of exposure to TGF-β1 were reduced to a similar extent (20–50% of control level). In both control and dexamethasone-treated explants, TGF-β1 (10 ng/ml) also decreased fatty acid synthetase mRNA, protein, and enzyme activity and the rate of [3H]choline incorporation into phosphatidylcholine. By electron microscopy, well-differentiated type II cells lining potential air spaces were present in explants cultured with dexamethasone, whereas exposure to TGF-β1 with or without dexamethasone resulted in epithelial cells lacking lamellar bodies. We conclude that exogenous TGF-β1 disrupts culture-induced maturation of fetal lung epithelial cells and inhibits expression of surfactant components through effects on gene transcription.Keywords
This publication has 36 references indexed in Scilit:
- TGF-β signalling through the Smad pathwayTrends in Cell Biology, 1997
- Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurityThe Journal of Pediatrics, 1996
- Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease.Archives of Disease in Childhood: Fetal & Neonatal, 1995
- Molecular and phenotypic variability in the congenital alveolar proteinosis syndrome associated with inherited surfactant protein B deficiencyThe Journal of Pediatrics, 1994
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- Transforming growth factor-β inhibits surfactant protein A expression in vitroBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.Journal of Clinical Investigation, 1991
- Fetal rat lung fibroblasts produce a TGFβ homolog that blocks alveolar type II cell maturationDevelopmental Biology, 1990
- Glucocorticoid stimulation of fatty acid synthesis in explants of human fetal lungBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976